耳鼻咽喉头颈外科围手术期全身性类固醇的使用:基于证据的临床指导
本文综述耳鼻咽喉各亚专科手术围手术期全身性皮质激素使用的证据。证据支持扁桃体切除术、鼻整形术和甲状腺切除术中用于恶心、呕吐或水肿,以及内镜下鼻窦手术治疗慢性鼻窦炎伴鼻息肉和真菌性鼻窦炎;中耳内耳、喉、唾液腺及面部整形重建手术证据稀少。获益需权衡风险,需进一步研究明确作用。
要点
- 证据支持扁桃体切除术、鼻整形术和甲状腺切除术围手术期使用全身性类固醇以减少恶心、呕吐或水肿。
- 强证据支持内镜下鼻窦手术前后使用全身性类固醇治疗慢性鼻窦炎伴鼻息肉和真菌性鼻窦炎。
- 中耳内耳、喉、唾液腺手术及面部整形重建手术的围手术期全身性类固醇获益证据稀少或缺乏。
核心结论
- 临床实践指南、系统评价和原始研究支持特定耳鼻咽喉适应证的围手术期全身性皮质激素使用。
- 许多研究支持扁桃体切除术、鼻整形术和甲状腺切除术围手术期使用类固醇以缓解恶心、呕吐或水肿,但正式的指南推荐有限。
- 强证据支持内镜下鼻窦手术前后使用围手术期类固醇治疗慢性鼻窦炎伴鼻息肉和真菌性鼻窦炎。
- 中耳内耳、喉、唾液腺手术及面部整形重建手术的围手术期全身性类固醇获益证据稀少或缺乏。
- 围手术期全身性类固醇的获益需与风险权衡,需进一步研究明确其在耳鼻咽喉科的作用。
研究设计与样本
- 综合文献综述,检索数据库中医学术语和关键词,涵盖耳鼻咽喉综合及亚专科手术(耳科、鼻窦鼻腔、睡眠、喉、头颈、面部整形和儿科手术)的围手术期全身性皮质激素使用。
- 围手术期定义为术前(手术前7天内)、术中(手术当天)和术后(手术后24小时内开始)时间段。
主要发现
- 许多研究支持扁桃体切除术、鼻整形术和甲状腺切除术围手术期使用类固醇以缓解恶心、呕吐或水肿,但正式的指南推荐有限。
- 强证据支持内镜下鼻窦手术前后使用围手术期类固醇治疗慢性鼻窦炎伴鼻息肉和真菌性鼻窦炎。
- 中耳内耳、喉、唾液腺手术及面部整形重建手术的围手术期全身性类固醇获益证据稀少或缺乏。
临床怎么用
- 虽然许多耳鼻咽喉手术常规进行围手术期全身性类固醇给药,但高级别证据仅限于特定情境。
- 证据支持在几种耳鼻咽喉手术中减少恶心、呕吐或水肿的获益,以及慢性鼻窦炎伴鼻息肉或真菌性鼻窦炎的获益。
- 这些获益需与风险权衡,需进一步研究明确围手术期类固醇在耳鼻咽喉科的作用。
局限性
- 许多研究支持扁桃体切除术、鼻整形术和甲状腺切除术围手术期使用类固醇以缓解恶心、呕吐或水肿,但正式的指南推荐有限。
- 中耳内耳、喉、唾液腺手术及面部整形重建手术的围手术期全身性类固醇获益证据稀少或缺乏。
- 围手术期全身性类固醇的获益需与风险权衡,需进一步研究明确其在耳鼻咽喉科的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To review and synthesize the available evidence for use of perioperative systemic steroids for otolaryngologic surgical procedures. DATA SOURCES: A comprehensive literature review with evidence-informed recommendations. REVIEW METHODS: Databases were queried for medical subject heading terms and keywords related to perioperative systemic corticosteroids use for comprehensive otolaryngology and subspecialty procedures including otologic, sinonasal, sleep, laryngeal, head and neck, facial plastics, and pediatric surgery. Perioperative period included preoperative (up to 7 days prior to surgery), intraoperative (on the day of surgery), and postoperative (initiated within 24 hours after surgery) timeframes. CONCLUSIONS: Evidence from clinical practice guidelines, systematic reviews, and original research studies supports perioperative systemic corticosteroid use for specific otolaryngologic indications. Numerous studies support perioperative steroid use for nausea, vomiting, or edema in tonsillectomy, rhinoplasty, and thyroidectomy, although formal guideline recommendations are limited. Strong evidence supports perioperative steroid use before and after endoscopic sinus surgery for chronic rhinosinusitis with polyposis and fungal sinusitis. Evidence of benefit is sparse or absent on systemic perioperative steroid use for the middle and inner ear, laryngeal, salivary gland surgery, and reconstructive facial plastic surgery. IMPLICATIONS FOR PRACTICE: Although perioperative administration of systemic steroids is routinely performed for many otolaryngologic surgeries, high-level evidence is limited to specific contexts. Evidence supports the benefit for reducing nausea, vomiting, or edema for several otolaryngologic procedures, as well as for either chronic rhinosinusitis with polyposis or fungal sinusitis. However, these benefits need to be weighed against risks, and further investigations are needed to define the role for perioperative steroids in otolaryngology.
引用
- Ikeda AK, Gray R, Lee V, et al. Perioperative Use of Systemic Steroids Within Otolaryngology-Head and Neck Surgery: Evidence-Based Guidance for Clinicians. Otolaryngol Head Neck Surg. 2024. PMID: 39624920. doi:10.1002/ohn.1067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。